Ticker: BAYRY

Bayer

Pharma Healthcare Drug Manufacturers - General
Price 14.06
Reco Sell Potential 43 Risk 70 Updated 2026-09-09

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Bayer AG is a global healthcare and life sciences company that operates in pharmaceuticals, consumer health, crop science, and animal health. Its core products include prescription medications, over-the-counter products, agricultural solutions, and veterinary products. Major business segments are Pharmaceuticals, Consumer Health, Crop Science, and Animal Health, with revenue primarily derived from pharmaceutical sales and crop protection products.

Investment Profile

The investment profile of Bayer is more aligned with value investors due to its current low stock price relative to earnings and modest dividend yield. The company faces significant risks, which may deter growth-focused investors. The stock may appeal to those seeking stability and potential recovery over time rather than immediate gains.

Fundamental metrics (experimental) Updated: 2026-09-08
EPS (TTM) — earnings per share for the last 12 months, $
-0.42
Revenue QoQ — quarter-over-quarter revenue growth
-20.2%
EPS surprise
26.1%
20d volatility
1.0%
Dividend yield
0.2%
last ex-date
2026-04-28
AI recommendation changes
Date Before After Reason
2026-08-10 Hold Sell Weak fundamentals and high risk limit upside potential.
2026-07-31 Sell Hold Positive revenue growth, but EPS remains negative.
2026-07-23 Hold Sell Weak fundamentals and negative momentum raise concerns.
News Page 1 of 1